Matt Gethers/Articles to Read/Social
Social
Religious beliefs and public attitudes toward nanotechnology in Europe and the United States
The legacy of Myriad for gene-based diagnostics: a new policy and regulatory option
Patents on genes, usefulness, and the requirement of industrial application
Proliferation-resistant biotechnology: an approach to improve biological security
Hearts and minds and nanotechnology
Six secrets to success—how to build a sustainable biotech business
The habits of successful bioentrepreneurs
Wasting cash—the decline of the British biotech sector
Bio-art: the ethics behind the aesthetics
Building today's platform company
The eccentric engineer (al-Jazari)
Playing to win (Business Plan Competitions)
A different perspective on science
Essential features for proactive risk management
A blueprint for biotech's blues
Beyond the biotech IPO: a brave new world
US objection to ‘gene’ patenting: USPTO and Myriad in the spotlight
Is it virtuous to be virtual? The VC viewpoint
The role of patents in biodiversity conservation
Harmonizing biosecurity oversight for gene synthesis
Ark's gene therapy stumbles at the finish line
Monsanto's alfalfa reaches Supreme Court
Chinese institute makes bold sequencing play
One year in—Obama's biotech scorecard
Patenting biotech beyond the central dogma
The importance of foreign-born talent for US innovation
Pacemakers and Implantable Cardiac Defibrillators: Software Radio Attacks and Zero-Power Defenses
Purpose-bound protection for DNA sequences: in through the back door?
Who invents life: intelligent designers, blind watchmakers, or genetic engineers?
Disclosing discoveries (IP issues with University research)
Has biology disproved free will and moral responsibility?
Reply to Anckarsäter: A belief in free will is based on faith
Bioethics. U.S. panel weighs guidelines for synthetic biology.
Synthetic biology, analytic ethics.
- Gaisser S and Reiss T. Shaping the science-industry-policy interface in synthetic biology. Syst Synth Biol. 2009 Dec;3(1-4):109-14. DOI:10.1007/s11693-009-9027-6 |
- Rabinow P and Bennett G. Synthetic biology: ethical ramifications 2009. Syst Synth Biol. 2009 Dec;3(1-4):99-108. DOI:10.1007/s11693-009-9042-7 |
- Weir L and Selgelid MJ. Professionalization as a governance strategy for synthetic biology. Syst Synth Biol. 2009 Dec;3(1-4):91-7. DOI:10.1007/s11693-009-9037-4 |
- Wellhausen R and Mukunda G. Aspects of the political economy of development and synthetic biology. Syst Synth Biol. 2009 Dec;3(1-4):115-23. DOI:10.1007/s11693-009-9032-9 |
- van den Belt H. Playing God in Frankenstein's Footsteps: Synthetic Biology and the Meaning of Life. Nanoethics. 2009 Dec;3(3):257-268. DOI:10.1007/s11569-009-0079-6 |
- Yearley S. The ethical landscape: identifying the right way to think about the ethical and societal aspects of synthetic biology research and products. J R Soc Interface. 2009 Aug 6;6 Suppl 4(Suppl 4):S559-64. DOI:10.1098/rsif.2009.0055.focus |
